Skip to main content
. 2003 Sep 30;89(7):1248–1254. doi: 10.1038/sj.bjc.6601272

Figure 1.

Figure 1

Age distribution of HPV-16, -18, -31, and -45 seroprevalence* and DNA-prevalence** in Guanacaste, Costa Rica women. *Population-based HPV-16, -18, -31, and -45 serology prevalence is shown in black lines and includes study virgins. Black dotted lines denote seroprevalence excluding study virgins. **HPV DNA prevalence does not include study virgins.